Sihuan Pharmaceutical Holdings Group (0460) Stock Statistics & Valuation Metrics

Sihuan Pharmaceutical Holdings Group has a market cap or net worth of HK$5.88B. The enterprise value is HK$3.52B.

Sihuan Pharmaceutical Holdings Group has 9.33B shares outstanding. The number of shares has decreased by -2.65% in one year.

Sihuan Pharmaceutical Holdings Group’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Sihuan Pharmaceutical Holdings Group is ―. Sihuan Pharmaceutical Holdings Group’s PEG ratio is ―.

In the last 12 months, Sihuan Pharmaceutical Holdings Group had revenue of HK$1.75B and earned -HK$37.80M in profits. Earnings per share was HK$0.00.

In the last 12 months, operating cash flow was HK$207.63M and capital expenditures -HK$99.90M, giving a free cash flow of HK$107.72M billion.

Sihuan Pharmaceutical Holdings Group pays an annual dividend of HK$0.02, resulting in a dividend yield of 2.21%

Sihuan Pharmaceutical Holdings Group upcoming earnings date is Sep 2, 2025, TBA.

Sihuan Pharmaceutical Holdings Group as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Sihuan Pharmaceutical Holdings Group has paid HK$59.29M in taxes.

Sihuan Pharmaceutical Holdings Group EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Sihuan Pharmaceutical Holdings Group has HK$4.86B in cash and marketable securities with HK$1.12B in debt, giving a net cash position of -HK$3.74B billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Sihuan Pharmaceutical Holdings Group is , which is 11.43% higher than the current price. The consensus rating is